1 |
Recruiting |
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection |
- Clostridium Difficile Infection
|
- Drug: ridinilazole
- Drug: vancomycin
|
- Physicians Research Group
Tempe, Arizona, United States
- Rajiv Parikh MD
Tempe, Arizona, United States
- Arkansas Gastroenterology
North Little Rock, Arkansas, United States
- (and 105 more…)
|
2 |
Recruiting |
Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With an Optimized Background Regimen in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance |
|
- Drug: Oral Lenacapavir
- Drug: Placebo oral tablet
- Drug: Subcutaneous Lenacapavir
- (and 2 more…)
|
- Ruane Clinical Research Group Inc
Los Angeles, California, United States
- Mills Clinical Research
Los Angeles, California, United States
- Eisenhower Health Center at Rimrock
Palm Springs, California, United States
- (and 30 more…)
|
3 |
Recruiting |
Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With Other Antiretroviral Agents in People Living With HIV |
|
- Drug: Oral Lenacapavir
- Drug: F/TAF
- Drug: Subcutaneous Lenacapavir
- (and 3 more…)
|
- Alabama Medical Group, PC (Drug Shipment Address)
Mobile, Alabama, United States
- Valleywise Community Health Center – McDowell
Phoenix, Arizona, United States
- Pueblo Family Physicians
Phoenix, Arizona, United States
- (and 54 more…)
|
4 |
Recruiting |
Pharmacokinetic, Safety, and Efficacy of B/F/TAF in HIV-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters |
|
|
- Miller Children’s & Women’s Hospital Long Beach
Long Beach, California, United States
- Midway Immunology and Research Center
Fort Pierce, Florida, United States
- University of South Florida
Tampa, Florida, United States
- (and 8 more…)
|
5 |
Recruiting |
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults |
|
- Drug: B/F/TAF
- Drug: Placebo to match DTG
- Drug: Placebo to match F/TDF
- (and 3 more…)
|
- Spectrum Medical Group
Phoenix, Arizona, United States
- University of California Davis, One Community Health
Sacramento, California, United States
- Yale University; School of Medicine
New Haven, Connecticut, United States
- (and 83 more…)
|
6 |
Recruiting |
Randomized, Double-blind, Efficacy, and Safety Study of Doravirine/Islatravir (DOR/ISL) in Treatment-naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020) |
|
- Drug: DOR/ISL
- Drug: BIC/FTC/TAF
- Drug: Placebo to BIC/FTC/TAF
- Drug: Placebo to DOR/ISL
|
- University of Alabama at Birmingham 1917 Research Clinic ( Site 5610)
Birmingham, Alabama, United States
- Pueblo Family Physicians ( Site 5606)
Phoenix, Arizona, United States
- Ruane Clinical Research Group, Inc. ( Site 5624)
Los Angeles, California, United States
- (and 21 more…)
|
7 |
Recruiting |
Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)) |
|
|
- Georgetown University Hospital ( Site 1018)
Washington, District of Columbia, United States
- Midway Immunology and Research ( Site 1030)
Fort Pierce, Florida, United States
- Orlando Immunology Center ( Site 1007)
Orlando, Florida, United States
- (and 43 more…)
|
8 |
Recruiting |
Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) (GS-US-540-5821) |
|
|
|
9 |
Not yet Recruiting |
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With CoronaVirus Induced Disease 2019 (COVID-19) and Pulmonary Distress |
|
|
- Major Inclusion/Exclusion Criteria:
- Hospitalized with confirmed positive COVID-19 test
- 18 years or older
- On ventilator
- Uncontrolled High Blood Pressure
|